Nanoparticles in cancer immunotherapies: An innovative strategy-Reference-Cited by-同舟云学术

Nanoparticles in cancer immunotherapies: An innovative strategy

Published:2020-11-04 Issue:2 Volume:37 Page:
ISSN:8756-7938
Container-title:Biotechnology Progress
language:en
Short-container-title:Biotechnol Progress

Author:

Nasirmoghadas Pourya¹,Mousakhani Akbar²,Behzad Farahnaz³,Beheshtkhoo Nasrin⁴,Hassanzadeh Ali⁵^ORCID,Nikoo Marzieh⁶⁷,Mehrabi Mohsen⁸^ORCID,Kouhbanani Mohammad Amin Jadidi⁴

Affiliation:

1. Department of Medical Biotechnology, Faculty of Medical Sciences Tarbiat Modares University Tehran Iran

2. Department of Plant Sciences, Faculty of Natural Sciences University of Tabriz Tabriz Iran

3. Research Institute for Fundamental Sciences (RIFS) University of Tabriz Tabriz Iran

4. Department of Medical Nanotechnology, School of Advanced Technologies in Medicine Tehran University of Medical Sciences Tehran Iran

5. Department of Tissue Engineering and Applied Cell Sciences, School of Advanced Technologies in Medicine Tehran University of Medical Sciences Tehran Iran

6. Department of Immunology, School of Medicine Kermanshah University of Medical Sciences Kermanshah Iran

7. Helal Iran Pharmaceutical and Clinical Complex Tehran Iran

8. Department of Medical Nanotechnology, School of Medicine Shahroud University of Medical Sciences Shahroud Iran

Publisher

Wiley

Subject

Biotechnology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/btpr.3070

Reference129 articles.

1. Application of nanomaterials in cancer immunotherapy

2. New opportunities for nanoparticles in cancer immunotherapy;Park W;Biomater Res,2018